In the present work, we developed novel cellular models deleted for endogenous murine frataxin and expressing a human frataxin cDNA carrying pathogenic missense mutations resulting in a classical (I154F) and an atypical (G130V) FRDA clinical presentation. This evidence concerns the gene FXN and Friedreich ataxia.